Other

Purdue Pharma owners up opioid settlement offer to $6 bn

The owners of Purdue Pharma, maker of OxyContin, have offered to pay up to $6 billion to victims of the US opioid crisis to settle an avalanche of litigation, according to a report filed Friday by a federal mediator.

Psychology & Psychiatry

Mental health care for detainees failing worldwide

A substantial majority of prisoners around the world experience psychological problems, yet authorities do little to address this issue. A new volume(verwijst naar een andere website) edited by Piet Hein van Kempen and Maartje ...

Other

US moves to block Purdue Pharma opioid settlement

The US Justice Department has challenged a plan that would dissolve Purdue Pharma, manufacturer of the OxyContin drug that has been blamed for the country's opioid crisis, while shielding its founders from lawsuits.

page 8 from 38